AI-generated summary
The authors report a case series of 10 patients with radiotherapy-induced xerostomia and hyposalivation who received biweekly photobiomodulation therapy over about four weeks. Most participants reported lower xerostomia scores and less dryness, and salivary flow changes were limited and not statistically significant. The authors describe the findings as suggestive but call for randomised clinical trials to assess long-term effectiveness.
- Participants
- 10
- Who or what was studied
- Ten adults (5 male, 5 female, mean age 52 years) with xerostomia and hyposalivation after radiotherapy for head and neck cancer, half with nasopharyngeal squamous cell carcinoma
- Limits stated in the abstract
- The abstract describes a small case series with no control group, non-significant salivary flow changes, short follow-up, and states that randomised trials are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.